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Chromatin factors that regulate neurogenesis in
the central nervous system remain to be explored.
Here, we demonstrate that the chromatin remod-
eler chromodomain-helicase-DNA-binding protein 7
(CHD7), a protein frequently mutated in human
CHARGE syndrome, is a master regulator of neuro-
genesis in mammalian brain. CHD7 is selectively ex-
pressed in actively dividing neural stem cells (NSCs)
and progenitors. Genetic inactivation of CHD7 in
NSCs leads to a reduction of neuronal differentiation
and aberrant dendritic development of newborn neu-
rons. Strikingly, physical exercise can rescue the
CHD7 mutant phenotype in the adult hippocampal
dentate gyrus. We further show that in NSCs, CHD7
stimulates the expression of Sox4 and Sox11 genes
via remodeling their promoters to an open chromatin
state. Our study demonstrates an essential role of
CHD7 in activation of the neuronal differentiation
program in NSCs, thus providing insights into epige-
netic regulation of stem cell differentiation and
molecular mechanism of human CHARGE syndrome.
INTRODUCTION
Epigenetic regulations are essential for the maintenance of cell
identity and the guidance of stepwise cell differentiation. Muta-
tions in epigenetic regulators are linked to many human dis-
eases, including cancer and mental retardation (Berdasco and
Esteller, 2010; Jakovcevski and Akbarian 2012). As one family
of chromatin regulators, ATP-dependent chromatin remodelers
utilize the energy from ATP hydrolysis to slide nucleosomes,
dissociate core histones, or relocate the entire histone octamers
(Li et al., 2007). The dynamic change of nucleosome occupancy
at gene promoters provides temporal control of transcrip-
tion. Chromodomain-helicase-DNA-binding protein 7 (CHD7)
belongs to the CHD family of chromatin remodelers. CHD pro-
teins are involved in the regulation of multiple biological pro-62 Cell Stem Cell 13, 62–72, July 3, 2013 ª2013 Elsevier Inc.cesses, including chromatin structure reorganization and gene
expression (Hall and Georgel, 2007). Importantly, de novo het-
erozygous mutations of the CHD7 gene are the major cause of
the human CHARGE syndrome, a genetic disease characterized
by a complex constellation of birth defects (coloboma of the eye,
heart defects, atresia of the choanae, severe retardation of
growth and development, genital abnormalities, and ear abnor-
malities) (Vissers et al., 2004). It has been shown that CHD7
cooperates with another chromatin remodeling complex PBAF
(polybromo- and BRG1-associated factor-containing complex)
to regulate neural crest migration, implicating its role in the
peripheral system (Bajpai et al., 2010). Interestingly, most of
the CHARGE patients have mental retardation and olfactory
anomalies ranging from absence to hypoplasia of the olfactory
bulbs (OBs) (Blustajn et al., 2008; Vissers et al., 2004), suggest-
ing that the corresponding neurogenic systems are impaired in
those patients. A recent study identified CHD7 as a transcrip-
tional cofactor of the essential NSC regulator Sox2 in NSCs using
both proteomic and genomic approaches (Engelen et al., 2011),
suggesting a role of CHD7 in neurogenesis. However, the func-
tion of CHD7 in mammalian neurogenesis and the molecular
mechanism underlying its role in the human CHARGE syndrome
remains largely unknown.
The subventricular zone (SVZ) of the lateral ventricle (LV) and
the subgranular zone (SGZ) of the dentate gyrus (DG) in the hip-
pocampus are the major germinal zones of active neurogenesis
during adulthood in the mammalian central nervous system
(CNS) (Alvarez-Buylla and Garcia-Verdugo, 2002; Gage, 2000).
Astrocyte-like type B cells in the adult SVZ aremultipotent neural
stem cells (NSCs) (Doetsch et al., 1999). These cells give rise to
transit amplifying type C cells, which in turn differentiate into type
A cells (neuroblasts) that migrate to the OB through the rostral
migratory stream (RMS) (Alvarez-Buylla and Garcia-Verdugo,
2002). NSCs in the SGZ are also astrocyte-like cells with their
cell bodies residing in the SGZ and their radial processes
extending into the granular layer (GL) of the DG (Ming and
Song, 2005). The SGZ NSCs mainly give rise to newborn granule
cells that are integrated into GL. The adult neurogenic system
has been used to study many human neurological-disease-
related genes, in particular their roles in regulating NSC self-
renewal, differentiation, and maturation of newborn neurons
(Zhao et al., 2008). Molecularly, adult neurogenesis represents
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scription factors important for cell-fate commitment (Suh et al.,
2009). Epigenetic regulation is proposed to be actively involved
in regulation of this process (Ma et al., 2010). As a group of
important epigenetic regulators, the roles of chromatin remodel-
ers in adult neurogenesis remain largely unknown.
To gain insights into the mechanism of chromatin remodelers
in regulating adult NSCs, we investigated the function of CHD7
using mouse genetic approaches. Here, we demonstrate that
CHD7 expression is specifically enriched in active NSCs and
progenitors in the SVZ and SGZ. A NSC-specific inactivation of
CHD7 in adult mice leads to a dramatic decrease of neurogene-
sis. Strikingly, physical exercise can rescue the hippocampal
neurogenesis defect in CHD7 mutants. We further show that
loss of CHD7 in NSCs represses the expression of Sox4 and
Sox11 genes by inducing chromatin condensation of their pro-
moters. And, forced expression of Sox4 and Sox11 in CHD7
mutant NSCs can rescue the neuronal differentiation defect. In
summary, our study reveals that the CHARGE syndrome protein
CHD7 is amaster regulator of governing the neurogenic potential
of NSCs. Rescue of the CHD7 mutant phenotype via physical
exercise indicates an alternative pathway to overcome CHD7
deficiency, demonstrating the advantage of using adult NSCs
to study human brain disease causing genes. These results pro-
vide significant insights into the molecular mechanism of chro-
matin regulation of NSCs fate commitment, which also provide
implication to molecular pathogenesis of CHARGE syndrome.
RESULTS
CHD7 Expression Is Enriched In Neurogenic Niches
of the Adult Mouse Brain
We first examined the expression of CHD7 in adult mouse brain,
particularly in adult NSCs, which to our knowledge has not been
reported yet. Data from the Allen Brain Atlas show that the
messenger RNA (mRNA) of the CHD7 gene is highly expressed
in adult neurogenic regions of the mouse brain, i.e., in the SVZ,
RMS, and SGZ (Figure S1A available online). Consistent with
the expression of the mRNA, immunostaining assays show
that CHD7 protein is present in both the SVZ and SGZ cells
(Figures S1B and S1C). To identify the CHD7-expressing cell
population in the above-mentioned regions, we performed coim-
munostainings of CHD7 with various cellular markers. Glial fibril-
lary acidic protein (GFAP) is a marker for astrocyte-like type B
cells, namely, the NSCs in the SVZ (Doetsch et al., 1997),
whereas Mash1 and DCX (doublecortin), respectively, mark
type C cells, i.e., the transit amplifying cells (Parras et al.,
2004), and type A cells, the neuroblasts. We found that some
of the GFAP-positive cells express CHD7 (Figure 1A), indicating
that CHD7 is expressed in a subpopulation of SVZNSCs.Most of
Mash1-positive or DCX-positive cells express CHD7 (Figures 1B
and 1C), demonstrating that CHD7 is expressed in most of type
C and A cells. We next analyzed the proliferation state of CHD7-
expressing cells by costaining of CHD7 with a proliferation
markerMCM2 (minichromosomemaintenance complex compo-
nent 2). In both the SVZ and SGZ, CHD7 colabels with MCM2 in
most of the cells (Figures 1D and 1E), demonstrating that CHD7
is expressed in most fast-dividing cells. To further determine the
expression of CHD7 in the adult NSCs, we made use of a trans-genic mouse in which GFP expression is under the control of the
Tlx BAC-based promoter. Tlx has been shown to be specifically
expressed in NSCs, i.e., type B cells in the SVZ and type 1 cells in
the SGZ (Liu et al., 2008; Niu et al., 2011). Our analyses demon-
strate that the expression of Tlx-GFP recapitulates endogenous
Tlx expression (Figures S1D–S1F). Adult Tlx-GFP mice were
injected with bromodeoxyuridine (BrdU) 30 min before sacrifice
in order to visualize dividing cells in neurogenic regions. Interest-
ingly, most of Tlx-GFPhigh cells in both the SVZ and SGZ were
negative for BrdU (Figures 1F and 1G, white arrows), suggesting
that they are in a quiescent state. In support of this finding, we
observed that Tlx-GFPhigh cells express NSC markers Nestin
and GFAP, but not proliferation markers Ki67 and MCM2
(Figures S1G–S1I, arrows). Costaining of CHD7 with GFP and
BrdU in these animals shows that some Tlx-GFP-positive cells
express CHD7, and many of these colabeled cells were BrdU
positive (Figures 1F and 1G, yellow arrows; Figure 1H). In
contrast, most Tlx-GFPhigh cells did not express CHD7 (Figures
1F and 1G, white arrows). Moreover, CHD7 is coexpressed
with Nestin and Sox2 in both cultured neurospheres and mono-
layer NSCs (Figures 1I and 1J). These data reveal that NSCs start
to express CHD7 upon exiting the quiescent state, and the
expression of CHD7 persists in neural progenitors and neuro-
blasts (Figure 1K). This intriguingly selective expression pattern
of this chromatin remodeler suggests that CHD7 is probably
involved in a temporal regulatory programduring NSCactivation,
lineage commitment, and progression.
Loss of CHD7 Leads to Reduction of Neurogenesis
in the Adult SVZ
To investigate the function of CHD7 in adult neurogenesis,
a CHD7 conditional knockout (KO) mouse line (CHD7fl/fl) was
established in which the exon 3 is flanked by two loxP sites (Fig-
ure S2A). We have previously generated a Tlx-CreERT2 mouse
line using a BAC-mediated transgenic approach, where the
Cre recombinase is only expressed in type B cells of the adult
SVZ (Liu et al., 2008). The CHD7fl/fl mice were crossed with
Tlx-CreERT2mice to achieve a tamoxifen (TMX)-inducible muta-
tion of CHD7 in adult SVZ NSCs and their derivatives. Twoweeks
post-TMX induction (2 wpi), CHD7 was completely removed
from the adult mouse SVZ as shown by immunohistochemistry
(IHC) assay using a CHD7 antibody (Figure S2B). NSCs in the
SVZ mainly give rise to neuroblasts that migrate to the OB and
differentiate into mature neurons. To investigate the role of
CHD7 in these processes, TMX-treated mice (Tlx-CreERT2;
CHD7fl/fl and the littermate control) were injected with BrdU
and traced for 4 weeks. As shown in Figure 2A, there was a
dramatic decrease of BrdU-positive cells in the OB of CHD7
mutants. The number of newborn neurons, as shown by costain-
ing of BrdU and a mature neuronal marker NeuN, was signifi-
cantly decreased (Figure 2B). Consistently, there were less
DCX-positive neuroblasts in the OB of CHD7mutants compared
to the control (Figure 2C). Moreover, the CHD7fl/fl mice were
mated to another NSC-specific cre line, Nestin-CreERT2. As
shown in Figure S2C, CHD7 is efficiently depleted in Nestin-
CreERT2; CHD7fl/fl mice upon TMX treatment. By applying the
same BrdU tracing approach as illustrated in Figure 2A, we
observed a similar mutant phenotype in these animals as in
the Tlx-CreERT2; CHD7fl/fl mice (data not shown). It has beenCell Stem Cell 13, 62–72, July 3, 2013 ª2013 Elsevier Inc. 63
Figure 1. CHD7 Is Highly Expressed in the SVZ and the SGZ of the Adult Mouse Brain
(A) Confocal images of the mouse subventricular zone (SVZ) sections coimmunostained for CHD7 and GFAP. DNA is stained with DAPI (DAPI staining is in blue if
not indicated). Arrows mark the CHD7 and GFAP double-positive cells. The scale bar represents 20 mm. (LV, lateral ventricle.)
(B and C) Coimmunostaining of CHD7 and Mash1 (B) or DCX (C) in the SVZ. Scale bar: 20 mm.
(D and E) Coimmunostaining of CHD7 and MCM2 in the SVZ (D) and the subgranule zone (SGZ) (E). Scale bar: 20 mm. (GL, granule layer.)
(F and G) Adult Tlx-GFP mice were injected with BrdU 30 min before being sacrificed. The SVZ (F) and SGZ (G) sections were coimmunostained for CHD7, GFP,
and BrdU. Yellow and blue arrows mark Tlx-GFP+/CHD7+ and Tlx-GFP+/BrdU+ cells, respectively, whereas white arrows mark the GFP-high cells that are
negative for both CHD7 and BrdU. Scale bar: 20 mm.
(H) Proportion of CHD7-positive cells among Tlx-GFP-, BrdU- (30 min pulse labeling), and DCX-positive cells. At least 1,000 cells were analyzed for each
population in the SVZ and SGZ, respectively.
(I) Neurospheres were costained for CHD7 and Nestin. Note that only the Nestin-positive cells that are on the surface of neurospheres express CHD7. Scale bar:
20 mm.
(J) Monolayered NSCs were coimmunostained for CHD7 and Nestin (left panel), or Sox2 (right panel). Scale bar: 20 mm.
(K) A schematic illustration of CHD7 expression in adult neurogenic niches.
See also Figure S1.
Cell Stem Cell
CHD7 Governs Adult Neurogenesisproposed that SVZ NSCs are already predetermined to generate
a certain subtype of neurons in the OB (Merkle et al., 2007). To
analyze whether the decrease of neurogenesis is restricted to
certain types of neurons, we performed BrdU costaining with
markers (calretinin [CR], tyrosine hydroxylase [TH], and calbindin
[CB]) representing different subtypes of interneurons in the OB.
As shown in Figure 2D, no preferential loss of certain types of64 Cell Stem Cell 13, 62–72, July 3, 2013 ª2013 Elsevier Inc.neurons was found in CHD7 mutants, indicating that there is a
panneuronal phenotype. We thus assessed whether the self-
renewal of NSCs is affected upon CHD7 inactivation. Immuno-
staining assays did not show any major change in expression
of two NSC markers Nestin and Sox2 in the SVZ of CHD7
mutants (Figure S2D), suggesting that the number of NSCs
was not altered. We then analyzed the cell proliferation in the
Figure 2. Loss of CHD7 Leads to a Decrease of Neurogenesis in the Adult SVZ
(A) A schematic diagram of the experimental design for experiments shown in (A), (B), (D), and the immunostaining of BrdU in the olfactory bulb (OB). Scale bar:
20 mm. Tamoxifen (TMX)-treated mice (Tlx-CreERT2; CHD7fl/fl and the littermate control) were injected with BrdU once per day for 5 consecutive days.
(B) Costaining of BrdU and NeuN in the OB. Scale bar: 20 mm. The right panel shows the quantification data of the number of BrdU/NeuN double-positive cells.
Data are represented as mean ± SD (n = 5; * p < 0.01, Student’s t test).
(C) DCX staining of the OB sections from the control and CHD7mutants (Nestin-CreERT2; CHD7fl/fl and the littermate control, 1 month post-TMX injection). Scale
bar: 20 mm.
(D) The OB sections were coimmunostained with BrdU and markers (Calretinin [CR], Tyrosine Hydroxylase [TH], and Calbindin [CB]) representing different
subtypes of interneurons in theOB. Arrowsmark double-positive cells. Scale bar: 20 mm.Quantification result is shown in the right panel. Value representsmean ±
SD (n = 3, * p < 0.05; Student’s t test).
(E) BrdU staining of the SVZ from the control and CHD7mutant mice (Tlx-CreERT2; CHD7fl/fl and the littermate control, 1month post-TMX injection) sacrificed 2 hr
after BrdU injection. Quantification data are shown in the right panel. Value represents mean ± SD (n = 5).
(F) The SVZ cells (Tlx-CreERT2; CHD7fl/fl and the littermate control, 1 month post-TMX injection) were isolated for neurosphere assays. For the primary neu-
rosphere formation assay, cells from one mouse were plated in four wells of one 24-well plate. For the secondary neurosphere formation, 200 cells dissociated
from the primary neurosphereswere seeded in a single well of one 96-well plate. The number of neurosphereswas counted 7 days after seeding. Value represents
mean ± SD (n = 4).
(G) Primary neurospheres obtained from (F) were passaged three times. Then 500 disassociated cells were plated into a single well of one 96-well plate and
numbers of neurospheres were counted 7 days later. Value represents mean ± SD (n = 4).
See also Figure S2.
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CHD7 Governs Adult NeurogenesisSVZ using a 2 hr BrdU-pulse labeling assay. As shown in Fig-
ure 2E, there was no significant difference of BrdU incorporation
in the control and CHD7 mutants. Analysis with the proliferation
marker Ki67 showed similar results (Figure S2E). We next moni-tored the self-renewal of NSCs using neurosphere formation
assay. The number of primary, secondary, and long-term
passaged neurospheres formed from the SVZ-derived cells
did not significantly differ between the control and CHD7Cell Stem Cell 13, 62–72, July 3, 2013 ª2013 Elsevier Inc. 65
Figure 3. Loss of CHD7 in the Adult SGZ Leads to a Decrease of Hippocampal Neurogenesis
(A) The scheme of BrdU tracing experiment and the dentate gyrus (DG) sections were coimmunostained with BrdU and NeuN. Mice (Nestin-CreERT2; CHD7fl/fl
and the littermate control) were injected with BrdU once per day for 10 consecutive days. Scale bar: 20 mm. The number of BrdU+ cells in the GLwas quantified as
shown in the right panel. Value represents mean ± SD (n = 3, * p < 0.05; Student’s t test).
(B) Confocal images of DCX staining in the GL of the control and CHD7 mutant mice (Nestin-CreERT2; CHD7fl/fl and the littermate control; 1 month post-TMX
injection). Scale bar: 20 mm.
(C) Quantification of Ki67-postitive cells in the SGZ of the control and CHD7 mutants (Nestin-CreERT2; CHD7fl/fl and the littermate control; 1 month post-TMX
injection). Value represents mean ± SD (n = 3, * p < 0.05; Student’s t test).
See also Figure S3.
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CHD7 Governs Adult Neurogenesismutants (Figures 2F and 2G). Thus, loss of CHD7 impairs neuro-
genesis in the SVZ-OB without affecting the self-renewal of
NSCs, which indicates that CHD7 is specifically required for
the neuronal differentiation of NSCs. Indeed, the number of
transit amplifying cells marked by Mash1 was slightly increased
in CHD7 mutants (Figure S2E), indicating a possible blockage of
these cells for further neuronal differentiation. Moreover, DCX
immunostaining showed that the chain-like structure of
migrating neuroblasts was not affected (Figure S2F), ruling out
a major defect in the migration of neuroblasts. To further confirm
the phenotype of CHD7 mutated NSCs observed in vivo, we
established a SVZ NSC culture and tested the neuronal differen-
tiation capacity of control and CHD7 mutant cells. In agreement
with the in vivo finding, CHD7 mutant cells, both adult and fetal
NSCs, generated significantly less Tuj1-positive neurons upon
induction of differentiation (Figure S2G), which demonstrates
an indispensable role of CHD7 during neuronal differentiation.
In the SVZ, the majority of NSCs differentiate into neuronal
lineage. The selective expression pattern of CHD7 in adult
SVZ and the neuronal differentiation defect in CHD7 mutants
suggest that CHD7, as a chromatin remodeler, plays a specific
role for initiating the neuronal differentiation program on the
chromatin level. These results also help to understand the olfac-
tion defect that is frequently associated in the human CHARGE
patient.
Loss of CHD7 Leads to Impairment of Neurogenesis
in the Adult SGZ
The adult hippocampal neurogenic system has often been used
to study functions of neurological disease genes linked to
learning disability (Zhao et al., 2008). Many CHARGE patients
have a learning disability (Bergman et al., 2011). The specific
expression pattern of CHD7 in the adult SGZ suggests a poten-
tial role in regulating the hippocampal neurogenesis. We gener-
ated a Nestin-CreERT2; CHD7fl/fl mouse line, which allows us to
ablate CHD7 in the SGZ NSCs upon TMX induction (Figure S3A).
NSCs in the SGZ generate neuroblasts that give rise to granule
cells in the GL. Using the same BrdU tracing approach as used
for the SVZ-OB system, we observed that loss of CHD7 in the66 Cell Stem Cell 13, 62–72, July 3, 2013 ª2013 Elsevier Inc.SGZ NSCs results in a significant reduction of the number of
BrdU-positive newborn neurons in the GL (Figure 3A). Moreover,
DCX-positive neuroblasts in CHD7 mutants have shorter and
less branched dendrites compared to the control (Figure 3B),
suggesting a possible defect of dendritic development of
newborn neurons. Both Sox2 and CCND2 have been shown to
be essential for the maintenance of the SGZ NSCs (Favaro
et al., 2009; Ferri et al., 2004; Suh et al., 2007). By analyzing
the RNA extracted from the microdissected hippocampus, we
did not observe significant alteration in the expression Sox2
and CCND2 genes in CHD7 mutants as compared to the control
(Figure S3B). Intriguingly, we observed a slight increase of Ki67-
positive cells and Tbr2-positive transit amplifying cells in the
SGZ of CHD7 mutants (Figures 3C and S3C). The accumulation
of these cells could be due to a possible blockage of further
neuronal differentiation. Thus, like in the SVZ-OB system, deple-
tion of CHD7 in the SGZ NSCs leads to reduction of adult hippo-
campal neurogenesis.
Ablating CHD7 in NSCs of the two adult neurogenic regions
results in similar phenotype of neuronal differentiation defect,
suggesting a general role of CHD7 in regulating neurogenesis.
In support of this, we observed a similar phenotype by ablating
CHD7 in radial glial cells during embryonic brain development
(Figures S3D and S3E). Moreover, we analyzed whether loss of
CHD7 in NSCs leads to an alternative fate of their progeny. There
was no significant change of glial differentiation in all systems
analyzed (SVZ, SGZ, and embryonic brain development) (Figures
S3F–S3H). Interestingly, we observed an increase of cell death of
newborn CHD7 mutant cells (Figures S3I and S3J), suggesting
that CHD7 mutant cells may undergo apoptosis if they cannot
be properly differentiated.
Physical Exercise Rescues the Defect of Neurogenesis
in the SGZ of CHD7 Mutants
Epigenetic regulators are considered to be essential players of
regulating cell responses to environmental stimuli (Ma et al.,
2010). Interestingly, environmental stimuli can greatly affect
the proliferation and survival of newborn cells in the adult
CNS. For example, exposure of rodents to an enriched
Figure 4. Voluntary Running Rescues the Hippocampal Neurogenesis Defect of CHD7 Mutants
(A) A schematic diagram of the experimental design and IHC staining of BrdU in the GL. Mice (Nestin-CreERT2; CHD7fl/fl and the littermate control) were kept in
running cages (only for the runners) and were injected with BrdU once per day for the first 12 consecutive days. Scale bar: 100 mm. The quantification of the
number of BrdU+ cells is shown in the right panel. Value represents mean ± SD (nonrunners: n = 4; runners: n = 5, * p < 0.05; Student’s t test).
(B) A schematic diagram of the experimental design and the representative images of reconstructed newborn neurons in GL with retrovirus-mediated expression
of GFP. Scale bar: 20 mm.
(C) Summaries of dendrite properties of newborn neurons. The cumulative distribution plots of total dendrite length (left) and branch numbers (right) are shown.
Each symbol represents a single GFP+ neuron (4–5 mice per group; the number of traced neurons: control: n = 23; mutant: n = 23; control runners: n = 28; mutant
runners: n = 29. * p < 0.05, Kolmogorov-Smirnov test).
(D) Sholl analysis of the dendritic complexity of GFP+ neurons. The data represent mean ± SEM (same groups of cells as (C) were analyzed; * p < 0.01, Student’s
t test).
See also Figure S4.
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SGZ without affecting SVZ neurogenesis (Kempermann et al.,
1997). Physical exercise, such as voluntary running, promotes
SGZ neurogenesis by increasing cell proliferation and survival
of the newborn granule neurons (van Praag et al., 1999). Given
that CHD7 is expressed in active, but not quiescent, NSCs, and
the chromatin remodeler identity of CHD7, we anticipated that
CHD7 is maybe involved in regulating exercise-induced hippo-
campal neurogenesis. To test this, we divided the control and
CHD7 mutant mice into nonrunner and runner groups. Running
was performed as a voluntary exercise in a running wheel and
newborn neurons were labeled with BrdU as illustrated in Fig-ure 4A. First, we confirmed the reduction of BrdU-positive cells
in the GL of CHD7 mutant nonrunners as compared to the con-
trol nonrunners (Figure 4A). As expected, one month of running
significantly increased the number of BrdU-positive cells in the
GL of the control runners as compared to the control nonrun-
ners (Figure 4A). To our surprise, after running, numbers of
BrdU-positive cells in CHD7 mutants were not significantly
different from the control runners (Figure 4A). Similar results
were obtained when older mice were used for this assay (Fig-
ure S4A). Moreover, there was no significant difference in the
number of Ki67-positive cells between the control and mutant
runners (Figure S4B), indicating that running attenuates theCell Stem Cell 13, 62–72, July 3, 2013 ª2013 Elsevier Inc. 67
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CHD7 Governs Adult Neurogenesisaccumulation of proliferating cells in CHD7 mutants (compared
to Figure 3C).
The observation that CHD7-mutated neuroblasts have shorter
and less branched dendrites indicates a defect of dendritic
development (Figure 3B). We therefore monitored the dendritic
development of newborn neurons in the control and CHD7
mutants. For this, retroviruses expressing GFP were stereotacti-
cally injected into the DG to label newborn cells. The animals
were analyzed 4weeks postretroviral injection, andGFP-positive
newborn neurons were traced. Intriguingly, the total dendritic
length of GFP-positive newborn neurons in the GL of CHD7
mutants was significantly shorter compared to the control (Fig-
ures 4B, 4C, and S4C). Although not statistically significant,
GFP-positive neurons in CHD7 mutants have less total dendrite
branch numbers as compared to the control (Figures 4B, 4C,
and S4C). Sholl analysis further demonstrated a decrease in
the dendritic complexity of CHD7 mutant neurons (Figure 4D).
Thus, loss of CHD7 in the SGZ NSCs not only reduces the num-
ber of newborn neurons but also leads to the dendritic abnormal-
ity in newborn neurons. To test whether running can have any
effect on the dendritic abnormality in CHD7 mutant neurons,
we applied the same retroviral-labeling approach to control
and CHD7 mutant running mice. Strikingly, all of these above-
mentioned defects of dendritic development in newborn neurons
of CHD7mutants were completely rescued after running (Figures
4B–4D; Figure S4C). Together, these results suggest that phys-
ical exercise is capable of overcoming the neurogenic defect in
the DG of CHD7 mutants, including both the number and the
dendritic development of newborn neurons. Our data demon-
strate that exercise-induced neurogenesis does not depend on
CHD7, which suggests an alternative pathway can guide the
neuronal differentiation in the absence of CHD7.
Sox4 and Sox11 Are Direct Target Genes of CHD7
All of our above-mentioned results suggest that CHD7 is impor-
tant for activation of a neuronal differentiation program in NSCs.
Next, we aimed to identify the direct target genes of CHD7 in
NSCs that are responsible for its function in neurogenesis. For
this, we took a computational approach by analyzing the expres-
sion profiling data from the Cancer GenomeAtlas Project (TCGA)
(Network, 2008) because we observed a heterogeneous expres-
sion of CHD7 in human brain tumors (data not shown). Because
CHD7 occupancy at genes is correlated with active gene expres-
sion (Engelen et al., 2011; Schnetz et al., 2009), we focused on
genes that are most positively correlated with CHD7 expression
in the database. Interestingly, Sox4 and Sox11, two group C
genes of the Sox gene family (Kuhlbrodt et al., 1998), are on
top of the list of genes correlated most with CHD7 expression
(Figure 5A). Several studies have shown that Sox4 and Sox11
are essential for neuronal property determination (Bergsland
et al., 2006; Mu et al., 2012) The data from the Allen Brain Atlas
demonstrate that the mRNAs of Sox4 and Sox11 genes are
enriched in the two neurogenic regions of the adult mouse brain
(Figure S5A). Thus, Sox4 and Sox11 genes could be candidate
genes that are regulated by CHD7 during neurogenesis. Immu-
nostaining results showed that the expression of Sox4 and
Sox11 is indeed reduced in both the SVZ and SGZ of CHD7
mutants (Figures 5B and 5C). Consistently, the mRNAs of both
Sox4 and Sox11 in the hippocampus were significantly downre-68 Cell Stem Cell 13, 62–72, July 3, 2013 ª2013 Elsevier Inc.gulated in CHD7 mutants (Figure 5D). Thus, loss of CHD7 results
in downregulation of two essential neurogenic fate determinants
Sox4 and Sox11.
To further test whetherSox4 andSox11 are direct target genes
of CHD7, we used monolayer cultured NSCs, in which CHD7 is
homogenously expressed (Figure 1J). We performed chromatin
immunoprecipitation (ChIP) assays to monitor the binding of
CHD7 to Sox4 and Sox11 genes. The results in Figure 5E show
that CHD7 is associated with the promoters but not with the 30
coding regions of the Sox4 and Sox11 genes. To unravel the
mechanism of how CHD7 regulates the Sox4 and Sox11 genes,
NSCs derived fromCHD7fl/fl mice were infectedwith retroviruses
encoding the Cre recombinase. As shown in Figure S5B, the
mRNA of CHD7 is completely depleted 7 days postinfection.
Given the fact that CHD7 is an active ATP-dependent nucleo-
some remodeler (Bouazoune and Kingston, 2012), wemonitored
the nucleosome occupancy at Sox4 and Sox11 promoters in the
control and CHD7 mutant NSCs. The chromatin was extensively
digested with micrococcal nuclease (MNase) to obtain mainly
mononucleosome (Figure S5C); DNA was precipitated and
quantified using primers encompassing various gene promoters.
For the normalization, DNA was amplified with a primer flanking
an intergenic region on the mouse chromosome 8, where CHD7
does not bind (Figure 5E). Importantly, quantitative real-time
PCR analysis revealed that there were 2-fold more DNA of
Sox4 and Sox11 promoters existing in the mononucleosomal
form in CHD7mutant NSCs as compared to the control, whereas
promoters of several genes required for neurogenesis, including
Pten, p21, Dlx1, and Nestin, were not affected (Figure 5F). These
data suggest that depletion of CHD7 in NSCs leads to a com-
pacted nucleosome organization at promoters of Sox4 and
Sox11, which is refractory for gene expression. A recent study
demonstrated that the genome-wide binding of CHD7 coordi-
nates with H3K4 methylation and that the chromodomains of
CHD7 recognizes H3K4 methylation (Schnetz et al. 2009). We
thus performed ChIP assays to examine whether loss of CHD7
leads to changes of H3K4 methylation on promoters of the
Sox4 and Sox11 genes. Consistent with the downregulation of
Sox4 and Sox11 gene expression, the level of the active histone
mark H3K4me3 on promoters of both Sox4 and Sox11 genes
was decreased in CHD7 mutant NSCs, whereas the level of a
repressive mark H3K27me3 was not changed (Figure S5D).
Together, these results demonstrate that the association of
CHD7 to the promoters of Sox4 and Sox 11 genes is essential
for keeping these regions as open chromatin structure.
We next investigate whether downregulation of Sox4 and
Sox11 is responsible for the neuronal differentiation defect in
CHD7 mutants. For this, CHD7 mutant cells were infected
with retroviruses encoding Sox4 and Sox11 together with GFP
or GFP alone (Figure S5E), and 24 hr later, the cells were induced
to differentiation. Importantly, overexpression of Sox4 or Sox11
in CHD7 mutant NSCs significantly increased the number of
Tuj1-positive neurons among GFP-positive cells as compared
to the transfection ofGFPalone (Figure 5G), suggesting that over-
expression of Sox4 or Sox11 was able to largely rescue the
neuronal differentiation defect of CHD7 mutant NSCs. These
data strongly support that Sox4 and Sox11 are important target
genes of CHD7 in adult neurogenesis. A recent study showed
that inactivation of Sox4 and Sox11 in adult mouse DG results
Figure 5. CHD7 Directly Regulates the Expression of Sox4 and Sox11
(A) List of the most positively correlated genes with CHD7 expression in 540 human GBMs from TCGA database.
(B and C) The SVZ and SGZ sections from mice (Nestin-CreERT2; CHD7fl/fl and the littermate control, 1 month post-TMX injection) were stained for Sox4 (B) or
Sox11 (C). Scale bar: 20 mm.
(D) Quantitative PCR analysis of Sox4 and Sox11 expression in microdissected hippocampus tissue from mice (Nestin-CreERT2; CHD7fl/fl and the littermate
control, 1 month post-TMX injection). Value represents mean ± SD (n = 4, * p < 0.05; Student’s t test).
(E) ChIP analyses show enriched occupancy of CHD7 protein on promoter regions of Sox4 and Sox11 genes. As a negative control, no CHD7 occupancy was
detected in one intergenic region on mouse chromosome 8. Value represents mean ± SD. Data were summarized from three independent experiments.
(F) The control and CHD7mutant NSCswere digested withMNase tomostly mononucleosome. Ten nanograms of extracted DNAwere amplified with primers for
the individual promoter and normalized to the amount of DNA amplified from a primer for an intergenic region onmouse chromosome 8. Value represents mean ±
SD. Data were summarized from three independent experiments.
(G) The control and CHD7mutant NSCs were infected with retroviruses encoding GFP, Sox4-IRES-GFP, or Sox11-IRES-GFP and then induced to differentiation
for 2 weeks. The cells were stained with antibodies against GFP and Tuj1. Scale bar: 20 mm. The numbers of Tuj1+ cells among the total GFP+ cells were counted,
and the quantification data are shown on the right panel. Value represents mean ± SD (n = 5, * p < 0.05; Student’s t test).
See also Figure S5.
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genesis due to the blockage of neuronal differentiation (Mu et al.,
2012). These authors showed that Sox4 and Sox11 proteins are
expressed in DCX-positive neuroblasts in the DG, but not in
NSCs. Interestingly, both of Sox4 and Sox11 genes have been
shown to be transcribed, but not translated, in adult NSCs (Beck-
ervordersandforth et al., 2010). Our data showed that CHD7 is
immediately expressed when NSCs become activated, which
may be involved in the initiation of transcription of Sox4 and
Sox11 genes in these cells. Taken together, our data suggest
that in NSCs, CHD7 associates with promoters of the Sox4 and
Sox11 genes to keep them as an open chromatin structure for
permissive transcription, which is important for the activation of
Sox4 and Sox11-dependent neuronal differentiation program.
DISCUSSION
There are two unique features of stem cells: long-term self-
renewal and multiple lineage differentiation potential. For this,
the expression of genes in stem cells should not only allow
them to be kept in an undifferentiated status, but also allow
them to continuously generate new progenies. Epigenetic regu-
lations have been shown to be critical for stem cells to keep the
differentiation program in a poised state. For instance in embry-
onic stem cells, promoters of many developmentally important
transcription factors are modified as bivalent chromatin domain,
which keeps them at low transcriptional level while leaving these
genes poised for activation upon differentiation (Bernstein et al.,
2006). In line with this, inactivation of epigenetic regulators often
leads to aberrant differentiation of stem cell without affecting
self-renewal. For example, loss of the H3K4 methyltransferase
Mll1 or DNAmethyltransferase DNMT3a in NSCs leads to reduc-
tion of postnatal neurogenesis, without affecting NSC prolifera-
tion (Lim et al., 2009; Wu et al., 2010). Multiple lineage specific
genes expression was considered to be a hallmark of hemato-
poietic stem cells and epigenetic priming was shown to be
important for this process (Walter et al., 2008). The lineage
priming in NSCs was reported by Beckervordersandforth et al.
(2010), when they discovered genes that are important for
neuronal differentiaton like Sox4 and Sox11 are already tran-
scribed at low level in NSCs. The mechanism behind the activa-
tion of Sox4 and Sox11 in NSCs was unclear. The CHD7/Sox4/
Sox11 pathway we identified here provides an epigenetic mech-
anism of lineage priming in adult neurogenesis. CHD7 expres-
sion is associated with neurogenic cells that are undergoing
lineage commitment, and inducible inactivation of CHD7 in the
adult neurogenic niches lead to impaired neuronal differentia-
tion. In the adult mammalian brain, NSCs can generate neurons
very efficiently, both in the SVZ-OB andDG. The quiescent NSCs
are uncommitted and they are negative for CHD7 expression;
CHD7 expression appears upon NSC entering cell cycle, where
it targets promoters of Sox4 and Sox11 to keep them as a tran-
scriptional-permissive open chromatin state. This explains the
low level expression of Sox4 and Sox11 in NSCs and neural
progenitors (Beckervordersandforth et al., 2010). The protein
expression of CHD7 and Sox4 and Sox11 overlaps in neuro-
blasts, indicating that CHD7 is probably required for the main-
tenance of Sox4 and Sox11 expression in these cells. The
activation of Sox4 and Sox11 leads to sequential activation of70 Cell Stem Cell 13, 62–72, July 3, 2013 ª2013 Elsevier Inc.the downstream neuronal differentiation and maturation path-
way controlled by these factors (Bergsland et al., 2011). Notably,
the Sox4 and Sox11 double KO mice showed developmental
defects in many organs that are also affected in CHARGE
patients (Schilham et al., 1996; Sock et al., 2004), suggesting
the CHD7/Sox4/Sox11 regulation mechanism is probably a
general pathway beyond the nervous system. Two very recent
reports showed that several cell-cycle effectors regulate NSCs
by controlling the expression of Sox2, suggesting a general regu-
lation mechanism by targeting Sox factors in NSCs (Julian et al.,
2013; Marque´s-Torrejo´n et al., 2013).
The neuronal differentiation defect we observed in the CHD7
mutant provides insights into understanding human CHARGE
syndrome. It was known that around 80% of the CHARGE
patients have olfaction deficit, and most of them had anomalies
of the OBs (Blustajn et al., 2008; Bergman et al., 2011). The
mutant phenotype in mice observed in our study provides a
cellular mechanism for this clinical syndrome, which is that the
SVZ NSCs lacking CHD7 cannot efficiently differentiate into
neurons. The impaired neuronal differentiation and dendritic
development of newborn neurons in the hippocampus of adult
CHD7 mutant provides a possible cellular mechanism of the
learning and intellectual disability of 75% human CHARGE
patients (Bergman et al., 2011). It is striking that running exercise
leads to the rescue of neuronal differentiation defects in the DG
of CHD7 mutants. These data suggest that exercise-induced
neurogenesis is probably CHD7-independent, indicating an
alternative pathway that can sufficiently drive neuronal differen-
tiation in the absence of CHD7. On the other hand, this finding
implicates that exercise might be beneficial for CHARGE pa-
tients, in particular, for the recovery of the hippocampal-related
learning ability. However, whether newborn neurons in the GL
of CHD7 mutants can be functionally integrated into the pre-
existing circuit needs to be further investigated. Our study dem-
onstrates the potential of using mouse adult NSCs to study
human brain disease-related gene mutations, which will not
only help to unravel the molecular mechanism of different
diseases but also provide possible treatment strategies.
Intriguingly, mutations of CHD8, which can interact with CHD7
biochemically (Batsukh et al., 2010), were recently identified as
one of the major genetic lesions in human autism patients (Neale
et al., 2012; O’Roak et al., 2012; Talkowski et al., 2012). Human
CHARGE patients also have autistic-like behavior (Hartshorne
et al., 2005); thus, the function of CHD7 in the CNS identified in
this study, in particular, the defect of dendritic development,
may also provide insights into the understanding of the molecu-
lar basis of autism. Moreover, we observed that CHD7 is widely
expressed in many tissues in the adult mouse, particularly in tis-
sue-specific stem cell niches like hair follicles and bronchioles in
the adult lung (data not shown). This suggests that CHD7 might
be required for cell lineage commitment in many different tis-
sues, although this needs to be further tested in different tissues
using animal models.EXPERIMENTAL PROCEDURES
Animals
Mice were housed according to standard conditions, and all animal experi-
ments were conformed to the local and international guidelines for the use
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et al., 2008, 2010). CHD7fl/fl mice were obtained from EUCOMM, and the
neomycin selection cassette was removed by crossing with Flp deleter
mice. Nestin-CreERT2 animals were generated as described elsewhere (Cor-
sini et al., 2009). The Tlx-GFP reporter animal was obtained from the GENSAT
project.
Immuonostaining, Confocal Imaging, and Analysis
Mice were perfused with 4% paraformaldehyde, and brains were postfixed
overnight at 4C. Coronal sections (7 mm for paraffin or 40 mm for vibratome)
were prepared using a Microtome or Vibratome (Leica), respectively. Sections
were blocked and peameablized in 5% normal swine serum in PBST
(PBS+0.2% Triton X-100) for 1 hr before being incubated overnight at 4C
with primary antibodies. For immunohistochemistry, sections were incubated
with biotinylated secondary antibodies (Vector Laboratories), amplified by a
horseradish peroxidase system (ABC Kit, Vector Laboratories) and visualized
using DAB staining (Sigma-Aldrich). Fluorescent images were captured using
confocal laser-scanning microscopes (LSM780, LSM700, Zeiss; Leica SP5).
To compare the control and CHD7 mutants, a series of sections containing
at least 15 sections through the OB, SVZ, or DG were analyzed from each
mouse. All experiments were carried out in a blind fashion to experimental
conditions.
GFP-positive newborn granule cells were imaged with z stacks scanning
with a 0.5 mm interval using a Leica SP5 confocal microscope. To analyze
the dendritic structure of newborn neurons, reconstructions of the dendritic
processes were made from the z stacks. The projection images were semiau-
tomatically traced with National Institutes of Health ImageJ software using the
NeuronJ plugin. The total dendritic length and branch number of each GFP-
positive neuron were subsequently analyzed. The Sholl analysis for dendritic
complexity was carried out by counting the number of traced dendrites that
cross a series of concentric circles with 10 mm intervals from the cell soma.
Voluntary Running
Three to four tamoxifen-injected, age-matchedmice were housed in a rat cage
with one running wheel. During the first 12 days, animals were injected with
BrdU once per day. The animals were sacrificed 18 days after the last BrdU
injection.
Retroviral Preparation and Stereotactic Injection
The following retroviral vectors were used in this study: CAG-GFP; CAG-Sox4-
IRES-GFP and CAG-Sox11-IRES-GFP. Mouse complementary DNAs of Sox4
and Sox11 (Life Technologies) were cloned into the vector CAG-IRES-GFP.
High titers of retroviruses were generated by cotransfection of retroviral
vectors and vectors expressing gal-pol and vsvg into HEK293T cells followed
by ultracentrifugation of viral supernatant. To infect monolayer cultured NSCs,
1 ml of 1:20 diluted retroviruses were used to infect cells in a single well of one
24-well plate. For the stereotactic injection, mice were anesthetized and
injected with 2 ml of CAG-GFP retroviruses into the left and right dentate gyrus.
The coordinates from bregma were (in mm) 1.9 anterior/posterior, ±1.6
medial/lateral, and 1.9 dorsal/ventral from dura. For the runner groups,
injectedmice rested for 1 day before being put into the running cages. Animals
were sacrificed 4 weeks postinjection. The brains were cut into 40 mm thick
sections and stained with antibody against GFP.
Statistics
Statistical significance was determined by either two-tailed Student’s t test or
Kolmogorov-Smirnov test as indicated.
SUPPLEMENTAL INFORMATION
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